Zusammenfassung
Hämaturie ist das Leitsymptom etlicher urologischer und nephrologischer Erkrankungen. Bei der Differenzialdiagnose wird zwischen schmerzhafter und schmerzloser und zwischen der mit bloßem Auge sichtbaren Makro- und der nicht sichtbaren Mikrohämaturie unterschieden. Als Grund für eine Hämaturie kommen prinzipiell renale (glomeruläre) und nicht renale (nicht glomeruläre) Ursachen in Frage. Um einerseits Frühsymptome maligner und relevanter gutartiger Erkrankungen nicht zu verpassen und um andererseits eine übermäßige Diagnostik zu vermeiden, ist ein differenziertes Vorgehen wichtig.
Abstract
Hematuria is the main symptom of many urological and nephrological diseases. In the differential diagnostics a distinction is made between painful and pain-free and between macrohematuria which is visible to the naked eye and microhematuria which is not visible. The reasons for hematuria are basically renal (glomerular) and non-renal (non-glomerular) causes. In order not to overlook early symptoms of malignant and relevant benign diseases and also to avoid excessive diagnostic tests, a differentiated approach is necessary.
Literatur
Feldman A, Hsu C, Kurtz M, Cho K (2013) Etiology and evaluation of hematuria in adults. Wolters Kluwer Health, http://www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults
Jichlinski P (2010) Hämaturie. In: Hubert J (Hrsg) Urologische Fragen in der Grundversorgung. UNI-MED, Bremen, S 31–47
Davis R, Jones JS, Barocas DA et al (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188(6 Suppl):2473–2481
Anderson J, Fawcett D, Feehally J et al (2008) Joint consensus statement on the initial assessment of haematuria. BAUS/RA Guidelines 2008:1–5
Roth S (1995) Hämaturiediagnostik und Erythrozytenmorphologie. In: Rathert P (Hrsg) Urinzytologie. Springer, Heidelberg, S 195–221
Rockall AG, Newman-Sanders AP, al-Kutoubi MA, Vale JA (1997) Haematuria. Postgrad Med J 73:129–136
Mariani AJ, Mariani MC, Macchioni C et al (1989) The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 141:350–355
Jones DJ, Langstaff RJ, Holt SD, Morgans BT (1988) The value of cystourethroscopy in the investigation of microscopic haematuria in adult males under 40 years. A prospective study of 100 patients. Br J Urol 62:541–545
Vester U, Hoyer PF (2001) Microsopic hematuria in childhood. Monatsschr Kinderheilkd 149:770–773
Khadra MH, Pickard RS, Charlton M et al (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 163:524–527
Foley SJ, Soloman LZ, Wedderburn AW et al (2000) A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol 163:496–498
Vasdev N, Kumar A, Veeratterapillay R, Thorpe A (2012) Hematuria secondary to benign prostatic hyperplasia: retrospective analysis of 166 men identified in a single one stop hematuria clinic. Curr Urol 6:146–149
Satasivam P, Reeves F, Lin M et al (2012) The effect of oral anticoagulation on the prevalence and management of haematuria in a contemporary Australian patient cohort. BJU Int 110(Suppl 4):80–84
Massry SG, Glassock RJ (2001) Massry & Glassock’s Textbook of Nephrology, 4th edn. Lippincott Willians & Wilkins, Philadelphia
Grossfeld GD, Litwin MS, Wolf JS Jr et al (2001) Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy – part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57:604–610
Rodgers M, Nixon J, Hempel S et al (2006) Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technol Assess 10:iii–iv, xi-259
Mowatt G, N’Dow J, Vale L et al (2011) Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 27:3–10
Choyke PL (2008) Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician 78:347–352
Chow LC, Kwan SW, Olcott EW, Sommer G (2007) Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement. AJR Am J Roentgenol 189:314–322
Patschan O, Horstmann M, Thomas C et al (2008) Diagnostic procedures in upper urinary tract urothelial carcinoma. Urologe A 47:1487–1496
Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). European Association of Urology, http://www.uroweb.org/gls/pdf/05_TaT1_Bladder_Cancer_LR.pdf
Horstmann M (2012) Currently available urine-based tumour markers in the detection of new and recurrent urothelial bladder cancer. Nephro-Urol Mon 4:345–349
Tombinski J (2013) Asymptomatische Mikrohämaturie: Wie viel Diagnostik ist notwendig? J Urol Urogynäkol 20:4
Loo RK, Lieberman SF, Slezak JM et al (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clinic Proc 88:129–138
Einhaltung ethischer Richtlinien
Interessenkonflikt. M. Horstmann, T. Franiel und M.O. Grimm geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horstmann, M., Franiel, T. & Grimm, M. Differenzialdiagnose der Hämaturie. Urologe 53, 1215–1226 (2014). https://doi.org/10.1007/s00120-014-3506-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-014-3506-4